BeiGene

BeiGene, which plans to change its name to BeOne Medicines Ltd., is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 11,000 colleagues spans six continents. 
Visit BeiGene to learn more:

Learn more about BeiGene’s science and medicines

Explore BeiGene’s medical educational platform for healthcare professionals

Pipeline Resource

Download the pipeline resource for an overview of BeiGene’s investigational compounds and combinations in our solid tumour oncology and haematology disease areas of interest.

Download Resource

ESMO only accepts content from third parties after careful evaluation of its educational and scientific relevance to the ESMO target audience. Eligible material should meet the essential criterion of non-promotional intent. Such material may be published in other resources, but the content donor has given permission to ESMO for use in OncologyPRO.